PT - JOURNAL ARTICLE AU - Johannes H. De Kock AU - Helen Ann Latham AU - Richard G. Cowden AU - Breda Cullen AU - Katia Narzisi AU - Shaun Jerdan AU - Sarah-Anne Munoz AU - Stephen J. Leslie AU - Adam Boggon AU - Roger W. Humphry TI - The mental health of NHS staff during the COVID-19 pandemic: a two-wave cohort study AID - 10.1101/2021.06.17.21259076 DP - 2021 Jan 01 TA - medRxiv PG - 2021.06.17.21259076 4099 - http://medrxiv.org/content/early/2021/06/23/2021.06.17.21259076.short 4100 - http://medrxiv.org/content/early/2021/06/23/2021.06.17.21259076.full AB - Background Health and social care workers(HSCWs) are at risk of experiencing adverse mental health (MH) outcomes (e.g., higher levels of anxiety and depression) as a result of the COVID-19 pandemic. This can have a detrimental impact on quality of care, the national response to the pandemic and its aftermath.Aims A longitudinal design provided follow-up evidence on the MH(changes in the prevalence of disease over time) of NHS staff working in a remote health board in Scotland during the COVID-19 pandemic and investigated the determinants of MH outcomes over time.Method A two-wave longitudinal study was conducted from July to September 2020. Participants self-reported levels of depression(PHQ-9), anxiety(GAD-7), and mental well-being(WEMWBS) at baseline and again 1.5 months later.Results The analytic sample of 169 participants, working in community(43%) and hospital(44%) settings reported substantial levels of probable clinical depression, anxiety and low mental well-being(MWB) at baseline(depression:30.8%, anxiety:20.1%, low-MWB:31.9%). Whilst the MH of participants remained mostly constant over time, the proportion of participants meeting the threshold for clinical anxiety increased to 27.2% at follow-up. Multivariable modelling indicated that working with, and disruption due to COVID-19 were associated with adverse MH changes over time.Conclusions HSCWs working in a remote area with low COVID-19 prevalence, reported similar levels of substantial anxiety and depression as those working in areas of the UK with high rates of COVID-19 infections. Efforts to support HSCW MH must remain a priority and should minimize the adverse effects of working with, and the disruption caused by the COVID-19 pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementCOV/UHI/20/01 - CSO ScotlandAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical permission for this study was granted by the Health Research Authority (20/SW/0098).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesPlease refer to the manuscript.